↓ Skip to main content

Dove Medical Press

Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States

Overview of attention for article published in Drug, Healthcare and Patient Safety, December 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#16 of 156)
  • High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

blogs
1 blog
twitter
8 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
43 Mendeley